Literature DB >> 27382118

To diet or not to diet - that is still the question.

Johannes Rieger1, Joachim P Steinbach1.   

Abstract

Mesh：

Year:  2016        PMID： 27382118      PMCID： PMC4933492          DOI： 10.1093/neuonc/now131

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  19 in total

1.  A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan.

Authors:  Sebastian Brandhorst; In Young Choi; Min Wei; Chia Wei Cheng; Sargis Sedrakyan; Gerardo Navarrete; Louis Dubeau; Li Peng Yap; Ryan Park; Manlio Vinciguerra; Stefano Di Biase; Hamed Mirzaei; Mario G Mirisola; Patra Childress; Lingyun Ji; Susan Groshen; Fabio Penna; Patrizio Odetti; Laura Perin; Peter S Conti; Yuji Ikeno; Brian K Kennedy; Pinchas Cohen; Todd E Morgan; Tanya B Dorff; Valter D Longo
Journal:  Cell Metab       Date:  2015-06-18       Impact factor: 27.287

2.  Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.

Authors:  Eugene J Fine; C J Segal-Isaacson; Richard D Feinman; Silvia Herszkopf; Maria C Romano; Norica Tomuta; Amanda F Bontempo; Abdissa Negassa; Joseph A Sparano
Journal:  Nutrition       Date:  2012-07-26       Impact factor: 4.008

3.  Ketone bodies inhibit the viability of human neuroblastoma cells.

Authors:  Robert Skinner; Angelica Trujillo; Xiaojie Ma; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2009-01       Impact factor: 2.545

Review 4.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial.

Authors:  Melanie Schmidt; Nadja Pfetzer; Micheal Schwab; Ingrid Strauss; Ulrike Kämmerer
Journal:  Nutr Metab (Lond)       Date:  2011-07-27       Impact factor: 4.169

6.  Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.

Authors:  Paolo E Porporato; Suveera Dhup; Rajesh K Dadhich; Tamara Copetti; Pierre Sonveaux
Journal:  Front Pharmacol       Date:  2011-08-25       Impact factor: 5.810

7.  Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy.

Authors:  Howard T Chang; Lawrence Karl Olson; Kenneth A Schwartz
Journal:  Nutr Metab (Lond)       Date:  2013-07-05       Impact factor: 4.169

8.  Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer.

Authors:  A M Poff; C Ari; P Arnold; T N Seyfried; D P D'Agostino
Journal:  Int J Cancer       Date:  2014-05-14       Impact factor: 7.396

9.  Fasting enhances the response of glioma to chemo- and radiotherapy.

Authors:  Fernando Safdie; Sebastian Brandhorst; Min Wei; Weijun Wang; Changhan Lee; Saewon Hwang; Peter S Conti; Thomas C Chen; Valter D Longo
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

Authors:  T N Seyfried; T M Sanderson; M M El-Abbadi; R McGowan; P Mukherjee
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640
View more
  3 in total

1.  What to eat or what not to eat-that is still the question.

Authors:  László G Boros; T Que Collins; Gábor Somlyai
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

2.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

Review 3.  Deuterium-Depleted Water Influence on the Isotope 2H/1H Regulation in Body and Individual Adaptation.

Authors:  Alexander Basov; Liliia Fedulova; Mikhail Baryshev; Stepan Dzhimak
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.